Hiring?
Logo

Animal Gut Health

Short Summary

Developed and patented a unique ingredient called Enzyme Rich Malt Extract (ERME). ERME, when used as a feed additive or supplement improves animal digestive health by creating more favourable conditions for the animal’s own microbiome to flourish

Overview

Target
€1,600,000
Minimum
€5,500
Investment Raised
€1,100,000
Previous Rounds €250,000
Stage Achieving Sales
Investor Role Monthly Involvement

Milestones

  • TEAM Experienced leadership, specialists in taking companies to exit
  • SIMON ROWLANDS Rowlands Racing & Research Ltd “A game changer"
  • STUART WILLIAMS Professional Racehorse Trainer “record breaking season"
  • Cumani “Vital to our yard routine, EquiNectar keeps horses consistent"
  • 3x patent families pending
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
60% raised

Ampersand Health

location_on London, United Kingdom

Ampersand Health is a digital medicine platform improving treatment of inflammatory condition. Revenue generating, they have 14,000 patients signed-up and integrations with 15 hospitals. The Founder has 2 previous exits including 1 in digital health.

€ 1,100,000

Target

€ 27,000

Min per Investor

20% raised

Digital Staff Passports

location_on London, United Kingdom

Pre-employment checks cost the NHS £200m and 40,000 lost clinical days pa. Truu's digital passport enables remote and secure onboarding of healthcare workers to organisations, reducing onboarding time from 2 months to 2 minutes.

€ 550,000

Target

€ 55,000

Min per Investor

20% raised

Senti Tech

location_on North West, United Kingdom

Senti is the Stethoscope unchained: a comfortable smart garment autonomously monitoring breath sounds. This is tech-enabled precision and predictive medicine. Our vision is to help people with asthma and COPD enjoy more days without breathlessness.

€ 270,000

Target

€ 5,500

Min per Investor

load one similar proposal